DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
up	IGKV3D-20; IGKV1-12; IGLC7; FCN1; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV2D-28; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGHG4; C1QA; C1QB; C1QC; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; CFH; IGLC2; IGLC3; IGHV1-2; MASP1; IGLV3-21; COLEC10;	GO:0006956~complement activation	62	92	67.3913043478261	0	0	0	0	0	0	0
down	LCE6A; LCE2B; KRT34; KRT75; KRT6B; KRT16; KRTAP2-3; KRT3; CASP14; KRT2; KRT76; DSG1; DSG2; KRT33B; LCE3E; LCE1C; LCE1D; LCE1E; LCE1F; LCE1B; LCE3A; LCE2A; LCE2C; LCE2D; KRT27; KRT77; KRTAP19-1; SPRR4; CNFN; KRTAP4-1; KRTAP3-1;	GO:0031424~keratinization	31	181	17.1270718232044	0	0	0	0	0	0	0
down	TGM5; KRT34; KRT75; CSTA; KRT6B; KRT16; KRT3; SPRR1B; SPRR2E; SPRR2D; TGM1; CASP14; SPRR2B; SPRR2A; KRT2; KRT76; DSG1; DSG2; KRT33B; LCE1A; LIPN; LIPM; SPINK6; KRT27; KRT77; LCE3D; SPRR2G; KLK5;	GO:0070268~cornification	28	113	24.7787610619469	0	0	0	0	0	0	0
down	NKX2-1; LHX1; DLX6; DLX5;	GO:0048646~anatomical structure formation involved in morphogenesis	4	8	50	0.00010064377566099	0.0067361060623929	0.262579610699526	0.266404074174644	0.254729396197969	0.262579610699526	0.0569779374746454
down	CHP2; FGF19; IGF2; FGF2; AR; FGF5; PTHLH; FOSL1; AREG; EPCAM; IL11; FLT4; MATK; AKR1C2; ISL1; TGFB2; CNBP; BNC1; MST1R; EGR4; EPGN; HAS2; WWTR1; HOXC10; HILPDA; REG1A;	GO:0008284~positive regulation of cell population proliferation	26	490	5.30612244897959	0.00010179230921636	0.0067361060623929	0.265474342436278	0.269444242495716	0.257189565720387	0.265474342436278	0.0569779374746454
down	GBX2; ISL1; ALX1; CORO1C; SEMA3A; SEMA3D; SEMA4A;	GO:0001755~neural crest cell migration	7	44	15.9090909090909	0.00012294340930862	0.00783572190720039	0.320513468067596	0.325431204439941	0.292236483926611	0.320513468067596	0.0662791334877785
down	LHX2; DLX2; SEMA3A; CRTAC1; NR2E1;	GO:0021772~olfactory bulb development	5	18	27.7777777777778	0.00012432955047314	0.00783572190720039	0.324002808533018	0.329100320102417	0.294288045969936	0.324002808533018	0.0662791334877785
up	UGT1A9; UGT2B11; UGT1A1; UGT1A3; UGT2B28; UGT1A7; UGT1A8; UGT1A10; UGT1A6;	GO:0052697~xenobiotic glucuronidation	9	9	100	0.00013675936537138	0.0311570012990223	0.527480872237436	0.529669022083378	0.527480872237436	0.527480872237436	0.275400767374218
down	CYP26A1; DKK1; RBP4; GJA1; NCOA1; TRIML2; RXRG;	GO:0032526~response to retinoic acid	7	46	15.2173913043478	0.00015755813238915	0.00969898549846743	0.410438934873755	0.417056376434099	0.341113356622526	0.410438934873755	0.0820397102095
down	SULT2B1; IL1A; FTH1; REG1A; INHBA; AR; PTHLH; FOSL1; WT1; AZGP1; MSX1; SSTR5; CDKN1A; CDKN2B; TGFB2; GPLD1; FGFBP1; GPNMB; IFNL1; HIST1H2AC; BTG4; NUPR1;	GO:0008285~negative regulation of cell population proliferation	22	396	5.55555555555556	0.00018386441679563	0.0109611535594013	0.478782941335825	0.486689111258037	0.373428630511928	0.478782941335825	0.0927158682438696
down	NKX2-1; DLX1; DLX2; CDK5R2; NCOA1; FEZ1; LHX5; HSD3B1;	GO:0021766~hippocampus development	8	64	12.5	0.00018634375148207	0.0109611535594013	0.485052785107845	0.493251910173056	0.376307726434951	0.485052785107845	0.0927158682438696
down	HOXD9; MSX1; HOXA11; WNT3; EN1; ALX4;	GO:0035115~embryonic forelimb morphogenesis	6	33	18.1818181818182	0.00019766102126739	0.0111836026785094	0.514313977337755	0.523208723294788	0.389208262210416	0.514313977337755	0.0945974734149335
down	UPK2; ENC1; LMX1B; IGF2; PIM1; EN2; HOXA11; HOXC12; TLX1; HOXD13; HMGA2; FOXL1; ALX1; TRIML1; HMX1; THEG; NKX1-2; EPHA8; FLT4; FST; MST1R; LTK; CDH10; SPINK6; ROS1; EPHA10;	GO:0007275~multicellular organism development	26	513	5.0682261208577	0.00020196104004099	0.0111836026785094	0.525300665146638	0.534590872988524	0.39422795016003	0.525300665146638	0.0945974734149335
down	FGF2; FBXW7; NR2E1;	GO:0090049~regulation of cell migration involved in sprouting angiogenesis	3	3	100	0.00020280050191479	0.0111836026785094	0.527281304978455	0.53681292856845	0.395104367952663	0.527281304978455	0.0945974734149335
down	DKK1; IL1A; PF4; REG1A; INHBA; AR; ALOX12; WT1; MT3; ID1; NKX2-1; HMGA2; WNT3; ACTC1; FOXD1; ARX; MYD88; GATA5; RIMS2; IL1F10; IL36A;	GO:0010628~positive regulation of gene expression	21	374	5.61497326203209	0.00022248107507794	0.0119512669694997	0.578228314127567	0.588907405731308	0.417152015771138	0.578228314127567	0.101090828413864
down	INHBA; MSX1; DLX5; DLX6; FOXF2; ALX1; VAX1; ALX4;	GO:0060021~roof of mouth development	8	66	12.1212121212121	0.000225751170561	0.0119512669694997	0.586501541117494	0.597563348474983	0.420574430755154	0.586501541117494	0.101090828413864
down	NUPR1; FOSL1; TGM1; FOXG1; TGFB2; NR2E1;	GO:0045787~positive regulation of cell cycle	6	35	17.1428571428571	0.0002624008558848	0.0134007458028016	0.681455022732835	0.694575065527075	0.459463898654291	0.681455022732835	0.113351370865204
down	KLK8; FST; KRT2; FERMT1;	GO:0043616~keratinocyte proliferation	4	11	36.3636363636364	0.00026325605657184	0.0134007458028016	0.683412722860517	0.696838781745681	0.460372039122155	0.683412722860517	0.113351370865204
down	UPK2; KRT3; WT1; AKR1C2; DLX5; DLX6; SIX1; ACTL8;	GO:0030855~epithelial cell differentiation	8	68	11.7647058823529	0.00027173720531303	0.0135714789144078	0.705158047787335	0.719288382463613	0.469290153575617	0.705158047787335	0.114795531700536
down	DKK1; INHBA; HOXC13; LHX2; TGFB2; ALX4;	GO:0001942~hair follicle development	6	37	16.2162162162162	0.0003427209280078	0.0165987281161042	0.889018087252234	0.907182296436647	0.522247893853386	0.889018087252234	0.140401781681873
down	EPCAM; GJA1; HMGA2; NR2E1;	GO:2000648~positive regulation of stem cell proliferation	4	12	33.3333333333333	0.00034489234846457	0.0165987281161042	0.894305859568646	0.912930046385733	0.523677806295585	0.894305859568646	0.140401781681873
down	PAX7; LHX1; LHX5; LHX3;	GO:0021527~spinal cord association neuron differentiation	4	13	30.7692307692308	0.00044316097658314	0.0205797737722033	1	1	0.578889053753006	0.996329271973315	0.174075801713015
down	GLI2; FST; MSX1; DLX1; DLX2; FOXC1; AMTN;	GO:0042475~odontogenesis of dentin-containing tooth	7	57	12.280701754386	0.00051501467964221	0.0235042044312575	1	1	0.616435769320014	0.996329271973315	0.198812352132077
down	KRT16; KRT2; FERMT1;	GO:0051546~keratinocyte migration	3	5	60	0.00054934952566898	0.0242354699074301	1	1	0.63340000309634	0.996329271973315	0.204997824598335
down	SEMA3A; SIX1; SIX4;	GO:0061551~trigeminal ganglion development	3	5	60	0.00054934952566898	0.0242354699074301	1	1	0.63340000309634	0.996329271973315	0.204997824598335
down	KCNK2; GJA1; CDKN1A; DNAJC2;	GO:2000279~negative regulation of DNA biosynthetic process	4	14	28.5714285714286	0.00055986628600335	0.024294525558211	1	1	0.638807432329825	0.996329271973315	0.205497351943444
down	GLI2; MSX1; NKX2-1; ISL1; LHX3;	GO:0021983~pituitary gland development	5	27	18.5185185185185	0.00063144959552707	0.0266461066908134	1	1	0.672607934188369	0.996329271973315	0.225388404949278
down	TRABD2B; KLK8; MMP1; ELANE; MMP10; DPEP1; ENDOU; CPS1; CASP14; MMP13; HTRA3; CTRB2; PRSS57; ADAMTS16; PYDC1; CASP10; PAPPA2; KLK9; KLK5; PLAU; CPA4; CPA2;	GO:0006508~proteolysis	22	436	5.04587155963303	0.0006341914323843	0.0266461066908134	1	1	0.674125456779734	0.996329271973315	0.225388404949278
down	NKX2-8; NUPR1; AR; CDKN2B; ISL1; TGFB2; TINF2;	GO:0050680~negative regulation of epithelial cell proliferation	7	60	11.6666666666667	0.00068105541280605	0.0281680262140254	1	1	0.696038631887786	0.996329271973315	0.23826169326033
down	NKX2-8; RBP4; GLI2; NKX2-1; WNT7B; FOXF1; FBXW7; LHX3;	GO:0030324~lung development	8	80	10	0.00073508950929668	0.0298766375176418	1	1	0.716930449825227	0.996329271973315	0.252714130191133
down	AR; HOXD9; HOXD10; HOXA11; FOXL2; MST1R; DEFB126;	GO:0007338~single fertilization	7	61	11.4754098360656	0.00074494071634467	0.0298766375176418	1	1	0.719536952650478	0.996329271973315	0.252714130191133
up	UGT1A9; UGT1A1; UGT1A3; UGT1A7; UGT1A8; UGT1A6; UGT1A10;	GO:0052696~flavonoid glucuronidation	7	7	100	0.0007873002054537	0.169400760873455	1	1	1	1	1
down	ID1; FOXF1; ERRFI1;	GO:0060426~lung vasculature development	3	6	50	0.00081051878345206	0.031550635585259	1	1	0.735248741923681	0.996329271973315	0.266873788062596
down	C1QL1; DKK1; EN1;	GO:0061743~motor learning	3	6	50	0.00081051878345206	0.031550635585259	1	1	0.735248741923681	0.996329271973315	0.266873788062596
down	CHP2; RASAL1; DPEP1; GPLD1; LCE1D; SYT3; SYT7; SYT8;	GO:0071277~cellular response to calcium ion	8	82	9.75609756097561	0.00085304950703446	0.0319100061338109	1	1	0.745026145642595	0.996329271973315	0.269913555022314
down	ISL1; SIX1; DMRTA2; ISL2;	GO:0048665~neuron fate specification	4	16	25	0.00085591629599568	0.0319100061338109	1	1	0.745626152507799	0.996329271973315	0.269913555022314
down	GLI2; EN2; TGFB2; EN1; ISL2; WNK1;	GO:0048666~neuron development	6	47	12.7659574468085	0.00107107173140863	0.0393767621255369	1	1	0.794622829626587	0.996329271973315	0.333071758306878
down	GLI2; FST; HOXD12; LHX1; SIX1;	GO:0007389~pattern specification process	5	31	16.1290322580645	0.00109927587265646	0.0398600443139951	1	1	0.800918219415754	0.996329271973315	0.337159642621871
down	CTSV; MMP1; ELANE; MMP10; MMP13; CTRB2; KLK5;	GO:0022617~extracellular matrix disassembly	7	66	10.6060606060606	0.00113883512432322	0.0401965686631098	1	1	0.809711773393812	0.996329271973315	0.34000616302178
down	TGFB2; SIX1; SIX4;	GO:0048699~generation of neurons	3	7	42.8571428571429	0.00113892808830118	0.0401965686631098	1	1	0.809777870782141	0.996329271973315	0.34000616302178
down	LHX1; EN1; FOXC1; CDK5R2; NCOA1; GBX2;	GO:0021549~cerebellum development	6	48	12.5	0.00118275510814203	0.0411941154112099	1	1	0.818487428384347	0.996329271973315	0.348443998726091
down	RBP4; GJC1; GATA4; GATA5;	GO:0048738~cardiac muscle tissue development	4	18	22.2222222222222	0.00124781602528257	0.0428957015444539	1	1	0.829797656812907	0.996329271973315	0.362837012643877
up	UGT1A9; UGT2B17; UGT2B7; UGT1A6; UGT1A1; UGT1A4; UGT1A3; UGT1A7; UGT1A10;	GO:0052695~cellular glucuronidation	9	14	64.2857142857143	0.00126909652109164	0.258695306641469	1	1	1	1	1
down	DLX2; DLX5; DLX1; DLX6;	GO:0009790~embryo development	4	19	21.0526315789474	0.00148433949359617	0.0497254325609743	1	1	0.863885585272968	0.996329271973315	0.420606884914817
down	NUPR1; INHBA; WT1; HOXA11; GATA4; TGFB2; NCOA1; SIX4;	GO:0008584~male gonad development	8	90	8.88888888888889	0.001485272739989	0.0497254325609743	1	1	0.864366569602663	0.996329271973315	0.420606884914817
down	HMGA2; ISL1; WWTR1;	GO:0048762~mesenchymal cell differentiation	3	8	37.5	0.00154041763128066	0.0497254325609743	1	1	0.872021157023413	0.996329271973315	0.420606884914817
down	MSX1; WNT3; WNT7B;	GO:0061180~mammary gland epithelium development	3	8	37.5	0.00154041763128066	0.0497254325609743	1	1	0.872021157023413	0.996329271973315	0.420606884914817
down	WT1; SIX1; SIX4;	GO:0072075~metanephric mesenchyme development	3	8	37.5	0.00154041763128066	0.0497254325609743	1	1	0.872021157023413	0.996329271973315	0.420606884914817
down	FLT4; FOXF1; STK40; ERRFI1; SLC7A11;	GO:0048286~lung alveolus development	5	34	14.7058823529412	0.00158999511129587	0.0507074344530141	1	1	0.879267296546617	0.996329271973315	0.428913233105652
up	UGT1A9; UGT1A1; UGT1A7; UGT1A10; UGT1A8; PPARGC1A;	GO:0051552~flavone metabolic process	6	6	100	0.00191221542323672	0.370300516709791	1	1	1	1	1
down	CYP26A1; GLI2; WT1; LHX1; TGFB2; FOXC1; SIX1; HAS2;	GO:0001822~kidney development	8	94	8.51063829787234	0.00191708968056314	0.0578330292838981	1	1	0.92148363863323	0.996329271973315	0.489185695116076
down	AR; DLX1; ISL1; DLX2; PA2G4;	GO:0045597~positive regulation of cell differentiation	5	36	13.8888888888889	0.00199594011887405	0.0582829321439041	1	1	0.9258632024094	0.996329271973315	0.492991237485754
down	FGF2; WNT3; WNT7B;	GO:0072089~stem cell proliferation	3	9	33.3333333333333	0.00202034224984493	0.0582829321439041	1	1	0.927221453842603	0.996329271973315	0.492991237485754
down	GJA1; GJC1; KCNQ1;	GO:0086014~atrial cardiac muscle cell action potential	3	9	33.3333333333333	0.00202034224984493	0.0582829321439041	1	1	0.927221453842603	0.996329271973315	0.492991237485754
down	LMX1B; EN1; DMRTA2; FOXA2;	GO:0071542~dopaminergic neuron differentiation	4	21	19.047619047619	0.00204771918752666	0.0582829321439041	1	1	0.92861374666511	0.996329271973315	0.492991237485754
down	FGF2; FGFBP1; FOXC2; PLK2;	GO:0090050~positive regulation of cell migration involved in sprouting angiogenesis	4	21	19.047619047619	0.00204771918752666	0.0582829321439041	1	1	0.92861374666511	0.996329271973315	0.492991237485754
down	HOXC11; GLI2; HOXA11; HOXD12; HOXD13; ALX4;	GO:0042733~embryonic digit morphogenesis	6	55	10.9090909090909	0.00223297211246076	0.0628795444859962	1	1	0.938756942244159	0.996329271973315	0.531872081729746
down	HOXC11; HOXA11; SIX1;	GO:0001759~organ induction	3	10	30	0.0025835942352842	0.0679389708094758	1	1	0.957189790290753	0.996329271973315	0.57466767818364
down	REG1A; CPS1; FOXF1;	GO:0007494~midgut development	3	10	30	0.0025835942352842	0.0679389708094758	1	1	0.957189790290753	0.996329271973315	0.57466767818364
down	HOXD9; HOXD10; ISL2;	GO:0048935~peripheral nervous system neuron development	3	10	30	0.0025835942352842	0.0679389708094758	1	1	0.957189790290753	0.996329271973315	0.57466767818364
down	NKX2-1; PLA2G4E; TNFAIP8L3; PLA2G4F; PLA2G4D; PLPPR5;	GO:0006644~phospholipid metabolic process	6	57	10.5263157894737	0.00263309073495621	0.0679389708094758	1	1	0.959704083523271	0.996329271973315	0.57466767818364
down	KCNK2; SCEL; FOSL1; GATA4; BDKRB1; SOST;	GO:0009612~response to mechanical stimulus	6	57	10.5263157894737	0.00263309073495621	0.0679389708094758	1	1	0.959704083523271	0.996329271973315	0.57466767818364
down	RASAL1; REG1A; SYT3; RIMS2;	GO:1903861~positive regulation of dendrite extension	4	23	17.3913043478261	0.00274357442371509	0.0679389708094758	1	1	0.963284172164543	0.996329271973315	0.57466767818364
down	RIMS4; POPDC3; RIMS2; GLRA4; GABRD; GABRA1; CHRNA9; CHRNB4;	GO:0042391~regulation of membrane potential	8	102	7.84313725490196	0.00307367528324032	0.0729027624179632	1	1	0.970297296530456	0.996329271973315	0.616654340104622
down	MT2A; DPEP1; MT3; CERS1; KCNQ1; GPLD1;	GO:0035690~cellular response to drug	6	59	10.1694915254237	0.00308466542909402	0.0729027624179632	1	1	0.970516622320811	0.996329271973315	0.616654340104622
down	DPEP1; CHAC2; CHAC1;	GO:0006751~glutathione catabolic process	3	11	27.2727272727273	0.0032346252787343	0.0751057290597342	1	1	0.973622208899026	0.996329271973315	0.635288324547701
down	ELANE; TGFB2; IFNL1;	GO:0050778~positive regulation of immune response	3	11	27.2727272727273	0.0032346252787343	0.0751057290597342	1	1	0.973622208899026	0.996329271973315	0.635288324547701
down	WNT3; SEMA3A; SEMA3D; SEMA4A;	GO:0048843~negative regulation of axon extension involved in axon guidance	4	25	16	0.00358596474255179	0.0818280058063328	1	1	0.98100178214035	0.996329271973315	0.69214928555503
down	KRT16; ALOX12; FLG2; GRHL1;	GO:0061436~establishment of skin barrier	4	25	16	0.00358596474255179	0.0818280058063328	1	1	0.98100178214035	0.996329271973315	0.69214928555503
down	ISL1; TGFB2; FOXC1; ALX1; WWTR1;	GO:0010718~positive regulation of epithelial to mesenchymal transition	5	42	11.9047619047619	0.00366601201785155	0.0822367272140089	1	1	0.982517634317251	0.996329271973315	0.695606491037755
down	FOSL1; TGFB2; DSG1; DSG2; NCOA1;	GO:0032570~response to progesterone	5	42	11.9047619047619	0.00366601201785155	0.0822367272140089	1	1	0.982517634317251	0.996329271973315	0.695606491037755
down	TALDO1; HK2; FBP2;	GO:0006002~fructose 6-phosphate metabolic process	3	12	25	0.00397746758426765	0.0862980057012825	1	1	0.989245890470861	0.996329271973315	0.72995916743145
down	MT2A; MT3; MT1X;	GO:0010038~response to metal ion	3	12	25	0.00397746758426765	0.0862980057012825	1	1	0.989245890470861	0.996329271973315	0.72995916743145
down	EMX2; ARX; LHX5;	GO:0021846~cell proliferation in forebrain	3	12	25	0.00397746758426765	0.0862980057012825	1	1	0.989245890470861	0.996329271973315	0.72995916743145
down	FGF2; FLRT3; MSX1;	GO:0048598~embryonic morphogenesis	3	12	25	0.00397746758426765	0.0862980057012825	1	1	0.989245890470861	0.996329271973315	0.72995916743145
up	CCR2; CXCR3; CCR5; CCR6; CCR8; GPR17; ACKR1; CCL26; CCL23; CCL2; CCL16; CCL21; CCL11; CCL13; CCL24; CCL14; TFF2; XCL2; CXCL13; CCL18; CCL19;	GO:0070098~chemokine-mediated signaling pathway	21	70	30	0.00425906136197585	0.722335768994108	1	1	1	1	1
up	TRGV2; TRGV5; TRGV8; TRGV4; TRDV1; LILRA5; CD300LB; TYROBP; LY86; JCHAIN; C1QA; C1QB; C1QC; TRGV3; S100B; CFI; RNASE3; KLRC2; MATR3; CRISP3; LILRA4; SIGLEC14; NAIP; SLAMF1; PRKD1; CD300E; COLEC12; TRIL; TICAM2; CLEC10A; ZNF683; LILRA2; DEFB108B; DEFB104A; CLEC4C; RNASE6; PLD4; PGLYRP3; SIGLEC10; CD180; TRGV9; RARRES2; LGR4; CD209; TLR8; TLR7; IL36B; CD84; CLEC4A; TRDC; IGHV3-15; IGHV1OR15-9; IGHV3-66; IGHV4-61; IGHV3-48; IGHV2-70; IGHV1-69-2; IGHV2-26; IGHV4-59; IGHV3-23; IGHV4-39; TRBC1; IGHV3-53; IGHV1-3; TRBC2; IGHV4-4; IGHV3-30; IGLC3; IGHV3-13; IGHV3-49; IGLC7; IGHV1-2; IGHV3-21; IGHV6-1; IGHV5-51; IGHV3-7; IGHV3-33; IGHV3-72; IGHV1-18; IGHV1-46; IGHG4; IGHA2; IGLL5; IGHV1-45; IGLC2; IGHV3-74; IGHV1-24; IGHV3-73; IGHV4-31; IGHG3; IGHV3-11; IGHV1-69; IGHV4-34; IGKC; IGHV2-5; IGHD; IGHG2; IGHV3-43; IGHV3-20;	GO:0045087~innate immune response	99	505	19.6039603960396	0.00428962630696217	0.722335768994108	1	1	1	1	1
down	RASAL1; CXCL14; PLAU; REG1A; FGF2; CGB7; AR; AREG; GJA1; ENDOU; LTK; CHRNB4; CAP2; GRIA2; MAP2K3; BCAM; GNGT1; MST1R; GRB14; FGFBP1; INSL4; GPNMB; ARTN; EPGN; ARHGAP27; CMTM8; CASKIN1; MYD88; SH3GL3; DPYSL5; CORO1C; GABRD; CHRNA9; PLPPR5; GLRA4; GABRA1;	GO:0007165~signal transduction	36	989	3.64004044489383	0.00469999257438469	0.0897697275130332	1	1	0.996329271973315	0.996329271973315	0.759325027542184
down	GATA4; ISL1; TGFB2;	GO:0003215~cardiac right ventricle morphogenesis	3	13	23.0769230769231	0.00481575417712532	0.0897697275130332	1	1	0.996329271973315	0.996329271973315	0.759325027542184
down	AREG; TGM1; HAS2;	GO:0010838~positive regulation of keratinocyte proliferation	3	13	23.0769230769231	0.00481575417712532	0.0897697275130332	1	1	0.996329271973315	0.996329271973315	0.759325027542184
down	LHX1; DLX6; FLRT3;	GO:0060322~head development	3	13	23.0769230769231	0.00481575417712532	0.0897697275130332	1	1	0.996329271973315	0.996329271973315	0.759325027542184
down	GATA4; ISL1; TGFB2;	GO:0060413~atrial septum morphogenesis	3	13	23.0769230769231	0.00481575417712532	0.0897697275130332	1	1	0.996329271973315	0.996329271973315	0.759325027542184
down	ID1; WNT7B; STK40;	GO:0060425~lung morphogenesis	3	13	23.0769230769231	0.00481575417712532	0.0897697275130332	1	1	0.996329271973315	0.996329271973315	0.759325027542184
down	IL1A; FLT4; GATA4; ISL1;	GO:0010575~positive regulation of vascular endothelial growth factor production	4	28	14.2857142857143	0.00515367861274885	0.0934337462995096	1	1	0.996329271973315	0.996329271973315	0.790317448295075
down	GLI2; FST; TGFB2; KRT27;	GO:0031069~hair follicle morphogenesis	4	28	14.2857142857143	0.00515367861274885	0.0934337462995096	1	1	0.996329271973315	0.996329271973315	0.790317448295075
down	TCF15; FOXF1; FOXC1; FOXC2; HES7;	GO:0001756~somitogenesis	5	46	10.8695652173913	0.00522410066200507	0.0934337462995096	1	1	0.996329271973315	0.996329271973315	0.790317448295075
down	CXCL14; KCNQ1; TGFB2; SIX1; LHX3;	GO:0048839~inner ear development	5	46	10.8695652173913	0.00522410066200507	0.0934337462995096	1	1	0.996329271973315	0.996329271973315	0.790317448295075
down	MAP2K3; KCNQ1; ACTC1; TNNI2; TNNT1;	GO:0060048~cardiac muscle contraction	5	46	10.8695652173913	0.00522410066200507	0.0934337462995096	1	1	0.996329271973315	0.996329271973315	0.790317448295075
down	DKK1; DLX1; HTRA3; RBPMS2; SOST;	GO:0030514~negative regulation of BMP signaling pathway	5	47	10.6382978723404	0.00567691401996773	0.0990688022316956	1	1	0.996329271973315	0.996329271973315	0.837982057729114
down	IGF2; IL1A; FGF2; FGF5; TGFB2;	GO:0051781~positive regulation of cell division	5	47	10.6382978723404	0.00567691401996773	0.0990688022316956	1	1	0.996329271973315	0.996329271973315	0.837982057729114
down	FLT4; TCF15; STK40;	GO:0003016~respiratory system process	3	14	21.4285714285714	0.00575273843437185	0.0990688022316956	1	1	0.996329271973315	0.996329271973315	0.837982057729114
down	IGF2; MTPN; POPDC3;	GO:0051146~striated muscle cell differentiation	3	14	21.4285714285714	0.00575273843437185	0.0990688022316956	1	1	0.996329271973315	0.996329271973315	0.837982057729114
down	TGFB2; FOXC1; FOXC2;	GO:0060038~cardiac muscle cell proliferation	3	14	21.4285714285714	0.00575273843437185	0.0990688022316956	1	1	0.996329271973315	0.996329271973315	0.837982057729114
down	RIMS2; SYT3; SYT7; SYT8;	GO:0017156~calcium-ion regulated exocytosis	4	29	13.7931034482759	0.00576373084385384	0.0990688022316956	1	1	0.996329271973315	0.996329271973315	0.837982057729114
down	LHX2; TCF15; FOXC2; HES7;	GO:0007498~mesoderm development	4	30	13.3333333333333	0.0064200453772979	0.106717154832836	1	1	0.996329271973315	0.996329271973315	0.902676311687614
down	MSX1; MMP13; HAS2; PAPPA2;	GO:0060349~bone morphogenesis	4	30	13.3333333333333	0.0064200453772979	0.106717154832836	1	1	0.996329271973315	0.996329271973315	0.902676311687614
down	LTK; DLX5; FOXC1; IL18; DUX4L9; OGFOD1; USP13; SDCBP2; LIPG;	GO:0008283~cell population proliferation	9	142	6.33802816901408	0.0064985238034323	0.106717154832836	1	1	0.996329271973315	0.996329271973315	0.902676311687614
down	TGFB2; FOXC2; FERMT1;	GO:0033630~positive regulation of cell adhesion mediated by integrin	3	15	20	0.00679131286405932	0.106717154832836	1	1	0.996329271973315	0.996329271973315	0.902676311687614
down	PLA2G4D; PLA2G4F; PLA2G4E;	GO:0046475~glycerophospholipid catabolic process	3	15	20	0.00679131286405932	0.106717154832836	1	1	0.996329271973315	0.996329271973315	0.902676311687614
down	SERPINB5; SIX1; SIX4;	GO:0050678~regulation of epithelial cell proliferation	3	15	20	0.00679131286405932	0.106717154832836	1	1	0.996329271973315	0.996329271973315	0.902676311687614
down	KCNK2; RBP4; GJA1;	GO:0060044~negative regulation of cardiac muscle cell proliferation	3	15	20	0.00679131286405932	0.106717154832836	1	1	0.996329271973315	0.996329271973315	0.902676311687614
down	NUPR1; NQO1; SLC6A1; CDKN1A; SLC7A11; PON3;	GO:0009636~response to toxic substance	6	71	8.45070422535211	0.00709683479222345	0.109855682426991	1	1	0.996329271973315	0.996329271973315	0.929223819604773
down	HOXD9; HOXD10; SIX1; SIX4; POPDC3;	GO:0007519~skeletal muscle tissue development	5	50	10	0.00720034353683263	0.11080993803486	1	1	0.996329271973315	0.996329271973315	0.937295473444008
down	ITPRIP; PYDC1; TRIB3; CAMK2N2; WWTR1; WNK1;	GO:0006469~negative regulation of protein kinase activity	6	72	8.33333333333333	0.00754824373690344	0.115492492321291	1	1	0.996329271973315	0.996329271973315	0.976903265079509
down	SLC6A15; SLC6A1; SLC6A2; SLC6A11;	GO:0006810~transport	4	32	12.5	0.00787715751238549	0.116489056525325	1	1	0.996329271973315	0.996329271973315	0.985332789849597
down	PFN2; SEMA3A; CORO1C;	GO:0010633~negative regulation of epithelial cell migration	3	16	18.75	0.00793402715841041	0.116489056525325	1	1	0.996329271973315	0.996329271973315	0.985332789849597
down	INHBA; CDKN1A; CDKN2B;	GO:0042326~negative regulation of phosphorylation	3	16	18.75	0.00793402715841041	0.116489056525325	1	1	0.996329271973315	0.996329271973315	0.985332789849597
down	GLI2; TGFB2; FOXF2;	GO:0048566~embryonic digestive tract development	3	16	18.75	0.00793402715841041	0.116489056525325	1	1	0.996329271973315	0.996329271973315	0.985332789849597
down	CAMSAP2; KNDC1; CSMD3;	GO:0050773~regulation of dendrite development	3	16	18.75	0.00793402715841041	0.116489056525325	1	1	0.996329271973315	0.996329271973315	0.985332789849597
down	REG1A; FOXC1; WNK1;	GO:1990869~cellular response to chemokine	3	16	18.75	0.00793402715841041	0.116489056525325	1	1	0.996329271973315	0.996329271973315	0.985332789849597
down	CDC42EP2; MYO1B; CGNL1; FHOD3; PACSIN1; CORO1C; RHOD; ACTC1;	GO:0007015~actin filament organization	8	121	6.61157024793388	0.00796543983040565	0.116489056525325	1	1	0.996329271973315	0.996329271973315	0.985332789849597
down	FLT4; EPHA10; ROS1; EPHA8; LTK; MST1R;	GO:0033674~positive regulation of kinase activity	6	73	8.21917808219178	0.00801998240218438	0.116642271530671	1	1	0.996329271973315	0.996329271973315	0.986628772263461
down	GABRD; CHRNB4; GABRA1; CHRNA9; GLRA4;	GO:0050877~nervous system process	5	52	9.61538461538462	0.00836138816521315	0.120285839528909	1	1	0.996329271973315	0.996329271973315	1
down	CTSV; GRHL1; ERRFI1;	GO:0045616~regulation of keratinocyte differentiation	3	17	17.6470588235294	0.00918310554584834	0.129684385492508	1	1	0.996329271973315	0.996329271973315	1
down	FOSL1; CDKN1A; HSD3B1;	GO:0051412~response to corticosterone	3	17	17.6470588235294	0.00918310554584834	0.129684385492508	1	1	0.996329271973315	0.996329271973315	1
down	SNCG; SYT7; SYT8; SYT3;	GO:0014059~regulation of dopamine secretion	4	34	11.7647058823529	0.00953586599958944	0.130110501551099	1	1	0.996329271973315	0.996329271973315	1
up	FMO1; CYP2F1; CYP2C19; CYP2A7; CYP2E1; CYP2A6; CYP2C9; CYP2G1P; CYP2C18;	GO:0006082~organic acid metabolic process	9	21	42.8571428571429	0.00976016234151122	1	1	1	1	1	1
up	CYP2C9; CYP2C19; CYP4A11; CYP2E1; CYP2G1P; CYP2A7; CYP2F1; CYP2C18; CYP2A6;	GO:0019373~epoxygenase P450 pathway	9	21	42.8571428571429	0.00976016234151122	1	1	1	1	1	1
down	NR2E1; WNT3; WNT7B; GATA5; GATA4;	GO:0045165~cell fate commitment	5	55	9.09090909090909	0.0103363975419195	0.13543983880378	1	1	0.996329271973315	0.996329271973315	1
down	SLC6A15; SLC38A3; SLC7A5; SLC7A11;	GO:0003333~amino acid transmembrane transport	4	35	11.4285714285714	0.0104439655297062	0.13543983880378	1	1	0.996329271973315	0.996329271973315	1
down	WNK1; NKAIN1; NKAIN4;	GO:0002028~regulation of sodium ion transport	3	18	16.6666666666667	0.0105404634656512	0.13543983880378	1	1	0.996329271973315	0.996329271973315	1
down	SYT8; SYT7; SYT3;	GO:0017158~regulation of calcium ion-dependent exocytosis	3	18	16.6666666666667	0.0105404634656512	0.13543983880378	1	1	0.996329271973315	0.996329271973315	1
down	GPAT3; LPIN2; DGAT2;	GO:0019432~triglyceride biosynthetic process	3	18	16.6666666666667	0.0105404634656512	0.13543983880378	1	1	0.996329271973315	0.996329271973315	1
down	GLI2; EN2; GBX2;	GO:0030902~hindbrain development	3	18	16.6666666666667	0.0105404634656512	0.13543983880378	1	1	0.996329271973315	0.996329271973315	1
down	FOSL1; CDKN1A; CDKN2B;	GO:0031668~cellular response to extracellular stimulus	3	18	16.6666666666667	0.0105404634656512	0.13543983880378	1	1	0.996329271973315	0.996329271973315	1
down	IFRD1; PAX7; MTPN;	GO:0043403~skeletal muscle tissue regeneration	3	18	16.6666666666667	0.0105404634656512	0.13543983880378	1	1	0.996329271973315	0.996329271973315	1
down	GRIK2; RIMS2; RIMS4;	GO:0050806~positive regulation of synaptic transmission	3	18	16.6666666666667	0.0105404634656512	0.13543983880378	1	1	0.996329271973315	0.996329271973315	1
down	ISL1; SIX1; SIX4;	GO:0060037~pharyngeal system development	3	18	16.6666666666667	0.0105404634656512	0.13543983880378	1	1	0.996329271973315	0.996329271973315	1
down	LHX1; SIX1; SIX4;	GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis	3	18	16.6666666666667	0.0105404634656512	0.13543983880378	1	1	0.996329271973315	0.996329271973315	1
down	NKX2-8; PTPRZ1; CTNNA2; SEMA4A; ISL2; ISL1;	GO:0007409~axonogenesis	6	78	7.69230769230769	0.0107005707477671	0.136832902267341	1	1	0.996329271973315	0.996329271973315	1
down	FLRT3; SEMA3A; SEMA3D; SEMA4A;	GO:0050919~negative chemotaxis	4	36	11.1111111111111	0.0114061247115762	0.14487843965584	1	1	0.996329271973315	0.996329271973315	1
down	ZIC2; CRYAB; WT1; MT3; ID1; NKX2-1; LHX1; HMGA2; FOXG1; FOXL2; FOXF2; FOXD1; IFNL1; ESX1; DMBX1; TRIB3; HMX1; SIX4; PA2G4; SIX1; ALX1;	GO:0045892~negative regulation of transcription, DNA-templated	21	530	3.9622641509434	0.0117017989756104	0.14487843965584	1	1	0.996329271973315	0.996329271973315	1
down	PSAPL1; SPNS2; SERINC2;	GO:0006665~sphingolipid metabolic process	3	19	15.7894736842105	0.0120077235878062	0.14487843965584	1	1	0.996329271973315	0.996329271973315	1
down	PLA2G4E; PLA2G4F; PLA2G4D;	GO:0036149~phosphatidylinositol acyl-chain remodeling	3	19	15.7894736842105	0.0120077235878062	0.14487843965584	1	1	0.996329271973315	0.996329271973315	1
down	NPPB; FOXC1; FOXC2;	GO:0097746~regulation of blood vessel diameter	3	19	15.7894736842105	0.0120077235878062	0.14487843965584	1	1	0.996329271973315	0.996329271973315	1
down	IL1A; FGF2; F3; GATA4; HK2; HMGA2; ISL1; NR2E1;	GO:0045766~positive regulation of angiogenesis	8	131	6.10687022900763	0.0121743769779153	0.14487843965584	1	1	0.996329271973315	0.996329271973315	1
down	PACSIN1; SYT8; ACTL8; ACTBL2;	GO:0048488~synaptic vesicle endocytosis	4	37	10.8108108108108	0.0124234419648092	0.14487843965584	1	1	0.996329271973315	0.996329271973315	1
down	GLI2; ADRA2C; FOXG1; NCOA1; GDF6; SH3GL3;	GO:0045666~positive regulation of neuron differentiation	6	81	7.40740740740741	0.0125834524414187	0.1460894675984	1	1	0.996329271973315	0.996329271973315	1
down	CRYAB; GJA1; MYL12A; GJC1; MYL7; TNNT1; TNNI2;	GO:0006936~muscle contraction	7	106	6.60377358490566	0.0127354856373562	0.147208866733981	1	1	0.996329271973315	0.996329271973315	1
down	INHBA; FOXL2; FOXC1; DMRTA1;	GO:0001541~ovarian follicle development	4	38	10.5263157894737	0.0134969559995782	0.154346583653912	1	1	0.996329271973315	0.996329271973315	1
down	TNNC2; TNNT1; TNNI2; ACTC1;	GO:0030049~muscle filament sliding	4	38	10.5263157894737	0.0134969559995782	0.154346583653912	1	1	0.996329271973315	0.996329271973315	1
down	HOXC11; GATA4; NKX2-1;	GO:0007492~endoderm development	3	20	15	0.0135862312018744	0.154346583653912	1	1	0.996329271973315	0.996329271973315	1
down	FGF5; EPCAM; MSX1;	GO:0023019~signal transduction involved in regulation of gene expression	3	20	15	0.0135862312018744	0.154346583653912	1	1	0.996329271973315	0.996329271973315	1
down	WT1; GJC1; FOXF1; HAS2; FBXW7;	GO:0001570~vasculogenesis	5	60	8.33333333333333	0.0142983740341732	0.161054451355134	1	1	0.996329271973315	0.996329271973315	1
down	ELANE; FGF2; MIF; MST1R; EPGN;	GO:0043406~positive regulation of MAP kinase activity	5	60	8.33333333333333	0.0142983740341732	0.161054451355134	1	1	0.996329271973315	0.996329271973315	1
down	IGF2; AR; ADRA2C; IL11; EPHA8; ADRA1B; FLT4;	GO:0043410~positive regulation of MAPK cascade	7	109	6.42201834862385	0.0145411500057615	0.16128265131815	1	1	0.996329271973315	0.996329271973315	1
down	DKK1; MT3; SEMA3A; ZNF365; RTN4RL1;	GO:0010977~negative regulation of neuron projection development	5	61	8.19672131147541	0.0151973413084852	0.16128265131815	1	1	0.996329271973315	0.996329271973315	1
down	FOXC1; CYP26C1; FOXC2;	GO:0014032~neural crest cell development	3	21	14.2857142857143	0.0152770689951984	0.16128265131815	1	1	0.996329271973315	0.996329271973315	1
down	PLA2G4E; PLA2G4F; PLA2G4D;	GO:0036150~phosphatidylserine acyl-chain remodeling	3	21	14.2857142857143	0.0152770689951984	0.16128265131815	1	1	0.996329271973315	0.996329271973315	1
down	FBXW7; TRIB3; DCUN1D5;	GO:0051443~positive regulation of ubiquitin-protein transferase activity	3	21	14.2857142857143	0.0152770689951984	0.16128265131815	1	1	0.996329271973315	0.996329271973315	1
down	CPE; RAB38; PACSIN1;	GO:0072657~protein localization to membrane	3	21	14.2857142857143	0.0152770689951984	0.16128265131815	1	1	0.996329271973315	0.996329271973315	1
down	FST; ID1; UBE2D1; DLX5; GDF6; TGFB2;	GO:0030509~BMP signaling pathway	6	85	7.05882352941176	0.0154396514075024	0.16128265131815	1	1	0.996329271973315	0.996329271973315	1
down	HMGA2; TGFB2; FOXF2; AKNAD1;	GO:0001837~epithelial to mesenchymal transition	4	40	10	0.0158164281737627	0.16128265131815	1	1	0.996329271973315	0.996329271973315	1
down	IGF2; FGF2; PAX3; LHX1; LHX3; LAMB4; LAMA3;	GO:0009887~animal organ morphogenesis	7	111	6.30630630630631	0.0158418924604152	0.16128265131815	1	1	0.996329271973315	0.996329271973315	1
down	PF4; PGLYRP4; DEFB126; RNASE7; REG1A;	GO:0061844~antimicrobial humoral immune response mediated by antimicrobial peptide	5	62	8.06451612903226	0.016133286498788	0.163619959242497	1	1	0.996329271973315	0.996329271973315	1
down	EMG1; NOL11; DDX21; LYAR; WDR3; PA2G4; ESF1; PIH1D2;	GO:0006364~rRNA processing	8	139	5.75539568345324	0.0165675734846069	0.16738308020517	1	1	0.996329271973315	0.996329271973315	1
down	CRYAB; MT3; HK2;	GO:2000378~negative regulation of reactive oxygen species metabolic process	3	22	13.6363636363636	0.0170810712416962	0.171914812078973	1	1	0.996329271973315	0.996329271973315	1
down	WT1; FOXC1; VAX1; FOXC2;	GO:0043010~camera-type eye development	4	42	9.52380952380952	0.0183716434584265	0.183508453714924	1	1	0.996329271973315	0.996329271973315	1
down	DLX1; DLX2; FBXW7; CHAC1;	GO:0045746~negative regulation of Notch signaling pathway	4	42	9.52380952380952	0.0183716434584265	0.183508453714924	1	1	0.996329271973315	0.996329271973315	1
down	PF4; NPPB; TGFB2; FOXC1; SEMA4A; PLK2;	GO:0016525~negative regulation of angiogenesis	6	89	6.74157303370786	0.0187158788268731	0.184657712016997	1	1	0.996329271973315	0.996329271973315	1
down	GLI2; HOXA11; DMBX1;	GO:0048589~developmental growth	3	23	13.0434782608696	0.0189988374225507	0.184657712016997	1	1	0.996329271973315	0.996329271973315	1
up	CD1A; CD1C; CD1E; CD1B;	GO:0048006~antigen processing and presentation, endogenous lipid antigen via MHC class Ib	4	5	80	0.0190432065688999	1	1	1	1	1	1
up	CCL24; HRH1; CCL11; CCL13; CCL18; CCL23; XCL2; CCL2;	GO:0048245~eosinophil chemotaxis	8	20	40	0.0195949500922714	1	1	1	1	1	1
up	TYROBP; CTLA4; IL10; FCGR2B; MNDA; CD300A; TNFRSF13B;	GO:0030889~negative regulation of B cell proliferation	7	16	43.75	0.0201109422063867	1	1	1	1	1	1
down	ME1; NCOA1; TNFAIP8L3; TRIB3; GRHL1; PSAPL1;	GO:0019216~regulation of lipid metabolic process	6	92	6.52173913043478	0.0214639420315238	0.202910909133727	1	1	0.996329271973315	0.996329271973315	1
up	UGT1A9; UGT1A1; CYP2C18; UGT1A3; UGT1A7; UGT1A8; ADH1B; ADH1C; ADH1A;	GO:0042573~retinoic acid metabolic process	9	25	36	0.0224781267158686	1	1	1	1	1	1
down	PHGDH; HAAO; ME1; SH3BGRL3; NDUFA4L2;	GO:0022900~electron transport chain	5	68	7.35294117647059	0.0225566777542978	0.209615183581024	1	1	0.996329271973315	0.996329271973315	1
down	GLI2; FOXF1; IL18; PLA2G4F;	GO:0071407~cellular response to organic cyclic compound	4	45	8.88888888888889	0.0226596374201874	0.209615183581024	1	1	0.996329271973315	0.996329271973315	1
down	IL1A; IL36A; IL1F10;	GO:0002437~inflammatory response to antigenic stimulus	3	25	12	0.023176963445533	0.209615183581024	1	1	0.996329271973315	0.996329271973315	1
down	CTSV; STC2; GJA1;	GO:0046697~decidualization	3	25	12	0.023176963445533	0.209615183581024	1	1	0.996329271973315	0.996329271973315	1
down	ISL1; FOXC1; FOXC2;	GO:0055010~ventricular cardiac muscle tissue morphogenesis	3	25	12	0.023176963445533	0.209615183581024	1	1	0.996329271973315	0.996329271973315	1
up	APOA1; APOC3; APOA4; LPL; GPIHBP1;	GO:0034371~chylomicron remodeling	5	9	55.5555555555556	0.0241768750306677	1	1	1	1	1	1
down	TNNC2; TNNT1; TNNI2;	GO:0003009~skeletal muscle contraction	3	26	11.5384615384615	0.0254374632958876	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	PLA2G4E; PLA2G4F; PLA2G4D;	GO:0036152~phosphatidylethanolamine acyl-chain remodeling	3	26	11.5384615384615	0.0254374632958876	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	DSCAM; AR; MIF;	GO:0042327~positive regulation of phosphorylation	3	26	11.5384615384615	0.0254374632958876	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	KRT76; EN1; TYRP1;	GO:0043473~pigmentation	3	26	11.5384615384615	0.0254374632958876	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	RASAL1; TGFB2; SPRY4;	GO:0046580~negative regulation of Ras protein signal transduction	3	26	11.5384615384615	0.0254374632958876	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	STC2; AREG; GJA1; REG1A;	GO:0043434~response to peptide hormone	4	47	8.51063829787234	0.0258289383323129	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	GABRD; GABRA1; CLDN17; ANO4; SLC26A10; GLRA4;	GO:1902476~chloride transmembrane transport	6	97	6.18556701030928	0.0266267851603135	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	GJA1; CASP10; PELI1; MYD88; DDX21; PLK2; IL36A; IL1F10; IL1A;	GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling	9	183	4.91803278688525	0.0272200775682085	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	CRYAB; PIM1; MT3; MSX1; PFN2; CDKN1A; DSG1; USP13; FBXW7;	GO:0050821~protein stabilization	9	183	4.91803278688525	0.0272200775682085	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	NUPR1; MT3; GATA4; DAPL1;	GO:0010507~negative regulation of autophagy	4	48	8.33333333333333	0.0275082736917212	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	INHBA; GDF6; TGFB2; INHBE;	GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation	4	48	8.33333333333333	0.0275082736917212	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	MT1G; FLT4; MAP2K3;	GO:0035924~cellular response to vascular endothelial growth factor stimulus	3	27	11.1111111111111	0.0278120306629673	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	PLA2G4E; PLA2G4F; PLA2G4D;	GO:0036151~phosphatidylcholine acyl-chain remodeling	3	27	11.1111111111111	0.0278120306629673	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
up	APOA1; IL10; ANGPT1; LILRB1;	GO:0002740~negative regulation of cytokine secretion involved in immune response	4	6	66.6666666666667	0.0286055627570212	1	1	1	1	1	1
up	PTH; SFRP4; TFAP2B; FGF23;	GO:0055062~phosphate ion homeostasis	4	6	66.6666666666667	0.0286055627570212	1	1	1	1	1	1
down	EPHA8; IL18; LAMA3; LMO7;	GO:0030155~regulation of cell adhesion	4	49	8.16326530612245	0.0292512601760275	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	EPHA8; LTK; FLT4; MATK; MAP2K3; MST1R; EPHA10;	GO:0018108~peptidyl-tyrosine phosphorylation	7	127	5.51181102362205	0.029330369956194	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
up	CCL21; IGF1; CCL19;	GO:0010560~positive regulation of glycoprotein biosynthetic process	3	3	100	0.0301092338351552	1	1	1	1	1	1
up	PAX6; NKX6-1; NKX6-2;	GO:0021912~regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification	3	3	100	0.0301092338351552	1	1	1	1	1	1
up	NEFL; NEFM; NEFH;	GO:0033693~neurofilament bundle assembly	3	3	100	0.0301092338351552	1	1	1	1	1	1
up	MYO7B; ANKS4B; USH1C;	GO:1904970~brush border assembly	3	3	100	0.0301092338351552	1	1	1	1	1	1
up	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.0301092338351552	1	1	1	1	1	1
down	MSX1; WNT3; ALX4;	GO:0035116~embryonic hindlimb morphogenesis	3	28	10.7142857142857	0.0303002768069878	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	INHBA; HMGA2; LAMA3;	GO:0035987~endodermal cell differentiation	3	28	10.7142857142857	0.0303002768069878	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	IGF2; IL1A; EPGN;	GO:0045840~positive regulation of mitotic nuclear division	3	28	10.7142857142857	0.0303002768069878	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	NUPR1; FTH1; C1QL4;	GO:0048147~negative regulation of fibroblast proliferation	3	28	10.7142857142857	0.0303002768069878	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	NR2E1; SIX1; SIX4; RXRG;	GO:0048856~anatomical structure development	4	50	8	0.0310582223053804	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
up	PTH; ADRA2A; NOS1; CAV3; LILRB2; LILRB1;	GO:0051926~negative regulation of calcium ion transport	6	14	42.8571428571429	0.0328676007281042	1	1	1	1	1	1
down	HOXC11; HOXA11; FOXC2;	GO:0001656~metanephros development	3	29	10.3448275862069	0.03290164903398	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	MMP13; DLX5; FOXC1;	GO:0001958~endochondral ossification	3	29	10.3448275862069	0.03290164903398	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	EN2; MSX1; EN1;	GO:0030901~midbrain development	3	29	10.3448275862069	0.03290164903398	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	RSL1D1; SIX1; FBXW7; SIX4;	GO:0032880~regulation of protein localization	4	51	7.84313725490196	0.0329294284833332	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	NKX2-8; AR; HOXD9; HOXC9; MLF1; NCOA1;	GO:0006351~transcription, DNA-templated	6	103	5.8252427184466	0.0338315866549475	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	CRYAB; AREG; NQO1; GJA1; SLC6A1; NCOA1;	GO:0032355~response to estradiol	6	103	5.8252427184466	0.0338315866549475	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	NUPR1; NQO1; TGFB2; GRIK2;	GO:0043525~positive regulation of neuron apoptotic process	4	52	7.69230769230769	0.0348650918871871	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	SLC5A12; SLC10A6; SLC38A3; SLC6A15; SLC5A1;	GO:0006814~sodium ion transport	5	77	6.49350649350649	0.0349547226035001	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	LHX1; LHX3; SEMA3A;	GO:0008045~motor neuron axon guidance	3	30	10	0.0356154408530485	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	SLCO1A2; NCOA1; SLC10A6;	GO:0015721~bile acid and bile salt transport	3	30	10	0.0356154408530485	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	GJA1; ADRA2C; ADRA1B;	GO:0045907~positive regulation of vasoconstriction	3	30	10	0.0356154408530485	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	KCNK2; MORN4; FLRT3;	GO:0048678~response to axon injury	3	30	10	0.0356154408530485	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	EPCAM; MSX1; HMGA2;	GO:0048863~stem cell differentiation	3	30	10	0.0356154408530485	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	RSL1D1; IGF2; DLX5; GPNMB; WWTR1; DDX21;	GO:0001649~osteoblast differentiation	6	106	5.66037735849057	0.0378634741892321	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	FGF19; FGF2; FGF5; FGFBP1; FLRT3;	GO:0008543~fibroblast growth factor receptor signaling pathway	5	79	6.32911392405063	0.0381825264656558	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	CPS1; HAAO; SLC30A3;	GO:0010043~response to zinc ion	3	31	9.67741935483871	0.038440801705537	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	FGF2; EPHA8; TNFAIP8L3;	GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity	3	31	9.67741935483871	0.038440801705537	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	RBP4; PAX7; DLX1;	GO:0048706~embryonic skeletal system development	3	31	9.67741935483871	0.038440801705537	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	DKK1; MSX1; DLX5;	GO:0060325~face morphogenesis	3	31	9.67741935483871	0.038440801705537	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	PHGDH; PTHLH; LHX1; DUX4L9; STK40; ZNF485; YBX2; MAPK4;	GO:0010468~regulation of gene expression	8	166	4.81927710843374	0.0396932969353807	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
up	BMP4; SPI1; SHH; BATF;	GO:0002320~lymphoid progenitor cell differentiation	4	7	57.1428571428571	0.0405379598417117	1	1	1	1	1	1
up	CYP2A6; UGT1A7; UGT1A8; CYP2A7;	GO:0009804~coumarin metabolic process	4	7	57.1428571428571	0.0405379598417117	1	1	1	1	1	1
up	POMC; SCT; SCTR; HTR4;	GO:0032098~regulation of appetite	4	7	57.1428571428571	0.0405379598417117	1	1	1	1	1	1
up	CD1C; CD1A; CD1B; CD1E;	GO:0048007~antigen processing and presentation, exogenous lipid antigen via MHC class Ib	4	7	57.1428571428571	0.0405379598417117	1	1	1	1	1	1
down	CPE; GLRA4; GAL; GPR1; NPPB; SSTR5;	GO:0007218~neuropeptide signaling pathway	6	108	5.55555555555556	0.0407144162949389	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	CDKN1A; CDKN2B; CDK5R2; CNPPD1;	GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity	4	55	7.27272727272727	0.0410601490388944	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
up	MUC2; MUC6; MUC4; TFF3; TFF2; TFF1;	GO:0030277~maintenance of gastrointestinal epithelium	6	15	40	0.0412298572344701	1	1	1	1	1	1
up	SCT; ADCYAP1; ADCYAP1R1; SCTR; FFAR4; GPR62;	GO:0043950~positive regulation of cAMP-mediated signaling	6	15	40	0.0412298572344701	1	1	1	1	1	1
down	ADRA2C; MT3; IL18;	GO:0032148~activation of protein kinase B activity	3	32	9.375	0.0413767462823966	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	FGF2; ID1; GPNMB;	GO:0045765~regulation of angiogenesis	3	32	9.375	0.0413767462823966	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	DLX2; SIX1; SIX4;	GO:0048701~embryonic cranial skeleton morphogenesis	3	32	9.375	0.0413767462823966	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	SEMA3A; SEMA3D; SEMA4A;	GO:0071526~semaphorin-plexin signaling pathway	3	32	9.375	0.0413767462823966	0.210409456726968	1	1	0.996329271973315	0.996329271973315	1
down	GAL; MAFA; RIMS2;	GO:0030073~insulin secretion	3	33	9.09090909090909	0.0444221634433231	0.213403750697779	1	1	0.996329271973315	0.996329271973315	1
down	HOXD8; HOXC8; TCF15;	GO:0048705~skeletal system morphogenesis	3	33	9.09090909090909	0.0444221634433231	0.213403750697779	1	1	0.996329271973315	0.996329271973315	1
down	DLX1; DLX5; GATA5;	GO:0071773~cellular response to BMP stimulus	3	33	9.09090909090909	0.0444221634433231	0.213403750697779	1	1	0.996329271973315	0.996329271973315	1
down	SYT7; MYD88; CORO1C; ELANE;	GO:0006909~phagocytosis	4	57	7.01754385964912	0.0455139858786064	0.217464838665472	1	1	0.996329271973315	0.996329271973315	1
down	ELANE; ALOX12; IL18; RBPMS2;	GO:0048661~positive regulation of smooth muscle cell proliferation	4	57	7.01754385964912	0.0455139858786064	0.217464838665472	1	1	0.996329271973315	0.996329271973315	1
down	ID1; DLX5; DLX6; EPGN;	GO:0050679~positive regulation of epithelial cell proliferation	4	57	7.01754385964912	0.0455139858786064	0.217464838665472	1	1	0.996329271973315	0.996329271973315	1
up	TNFRSF13B; CXCL13; LILRA1; TRPA1; ADGRL2; F2; IFNG; IL2RA; CD3D; CD3G; SAG; CCL2; EDN3; NPR1; EDNRB; LAMA1; KLRC1; ADCYAP1R1; GLP1R; GCGR; SCTR; CXCR3; CCR5; ADGRE1; LILRB2; CLEC1A; GPHA2; ADGRE3; CLEC4A; TRBV24-1; TRBV19; TRBV6-6; TRBV5-1; CD80; TRBV6-1; TRBV27; TRBV3-1; TRBV2; TRBV28; TRBV7-2; TRBV4-1; TRBV7-6; TRBV29-1; TRBV30; TRBV20-1; TRBV6-5; TRBV12-4; TRBV5-4; TRBV9; TRBV18; TRBV7-9;	GO:0007166~cell surface receptor signaling pathway	51	268	19.0298507462687	0.0469507018163263	1	1	1	1	1	1
down	AR; EN1; STK40; WWTR1; ETNK2;	GO:0035264~multicellular organism growth	5	84	5.95238095238095	0.0470255483253268	0.222890633840956	1	1	0.996329271973315	0.996329271973315	1
down	XPOT; SSB; NUP214;	GO:0006409~tRNA export from nucleus	3	34	8.82352941176471	0.0475758247526029	0.222890633840956	1	1	0.996329271973315	0.996329271973315	1
down	DKK1; KCNK2; MT3;	GO:0010942~positive regulation of cell death	3	34	8.82352941176471	0.0475758247526029	0.222890633840956	1	1	0.996329271973315	0.996329271973315	1
down	MSX1; GATA4; FOXD1;	GO:0030513~positive regulation of BMP signaling pathway	3	34	8.82352941176471	0.0475758247526029	0.222890633840956	1	1	0.996329271973315	0.996329271973315	1
down	MSX1; SIX1; SIX4;	GO:0034504~protein localization to nucleus	3	34	8.82352941176471	0.0475758247526029	0.222890633840956	1	1	0.996329271973315	0.996329271973315	1
up	GLI3; WNT5A; SHH;	GO:0007442~hindgut morphogenesis	3	4	75	0.0477987878996849	1	1	1	1	1	1
up	PAX6; NKX6-1; NKX6-2;	GO:0021913~regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification	3	4	75	0.0477987878996849	1	1	1	1	1	1
up	MESP1; ROBO2; ROBO1;	GO:0035481~positive regulation of Notch signaling pathway involved in heart induction	3	4	75	0.0477987878996849	1	1	1	1	1	1
up	CIDEA; APOA4; LY6D;	GO:0035634~response to stilbenoid	3	4	75	0.0477987878996849	1	1	1	1	1	1
up	BMP4; WNT5A; SULF1;	GO:0060686~negative regulation of prostatic bud formation	3	4	75	0.0477987878996849	1	1	1	1	1	1
up	CYP2E1; ADH1A; CYP2A6; CYP2C9; UGT1A1; CYP2C19; FMO1; UGT1A7;	GO:0017144~drug metabolic process	8	25	32	0.0495495141269099	1	1	1	1	1	1
